Business Wire
BusinessLucid pushes back Cosmos SUV launch as it resets finances, leaving a clearer opening for Tesla rivalsThe Apex TimesBusinessBooz Allen rolls out Vellox Ranger, an AI tool aimed at automating environment-specific cyber threat detectionThe Apex TimesBusinessMusk Flags Memory as a Key Constraint, Pointing to Rapid Demand Growth That Could Keep Prices ElevatedThe Apex TimesBusinessAMD reports revenue growth ahead of expectations, but shares slip as investors question where orders are coming fromThe Apex TimesBusinessPalantir shares surge, prompting ARK to trim stake while Wall Street traders debate the upsideThe Apex TimesBusinessArk Invest grows a roughly $870 million Tesla position as Cathie Wood doubles down on the disruption thesisThe Apex TimesBusinessJohnson & Johnson’s leadership shuffle renews debate over valuation after executive retirementThe Apex TimesBusinessAMD warns stronger-than-expected server CPU demand is tightening supply, but CEO Lisa Su expects 2027 to improveThe Apex TimesBusinessPfizer, Merck and Amgen ramp up cancer-focused partnerships as trading chatter swirls around SLS and IBRXThe Apex TimesBusinessApple heads to trial in Illinois biometric lawsuit tied to facial recognition in PhotosThe Apex TimesBusinessFiserv and Mastercard expand partnership aimed at simplifying merchants’ access to digital payments servicesThe Apex TimesBusinessEli Lilly wins FDA Breakthrough Therapy designation for olomorasib in KRAS G12C-mutant advanced pancreatic cancerThe Apex TimesBusinessLucid pushes back Cosmos SUV launch as it resets finances, leaving a clearer opening for Tesla rivalsThe Apex TimesBusinessBooz Allen rolls out Vellox Ranger, an AI tool aimed at automating environment-specific cyber threat detectionThe Apex TimesBusinessMusk Flags Memory as a Key Constraint, Pointing to Rapid Demand Growth That Could Keep Prices ElevatedThe Apex TimesBusinessAMD reports revenue growth ahead of expectations, but shares slip as investors question where orders are coming fromThe Apex TimesBusinessPalantir shares surge, prompting ARK to trim stake while Wall Street traders debate the upsideThe Apex TimesBusinessArk Invest grows a roughly $870 million Tesla position as Cathie Wood doubles down on the disruption thesisThe Apex TimesBusinessJohnson & Johnson’s leadership shuffle renews debate over valuation after executive retirementThe Apex TimesBusinessAMD warns stronger-than-expected server CPU demand is tightening supply, but CEO Lisa Su expects 2027 to improveThe Apex TimesBusinessPfizer, Merck and Amgen ramp up cancer-focused partnerships as trading chatter swirls around SLS and IBRXThe Apex TimesBusinessApple heads to trial in Illinois biometric lawsuit tied to facial recognition in PhotosThe Apex TimesBusinessFiserv and Mastercard expand partnership aimed at simplifying merchants’ access to digital payments servicesThe Apex TimesBusinessEli Lilly wins FDA Breakthrough Therapy designation for olomorasib in KRAS G12C-mutant advanced pancreatic cancerThe Apex TimesBusinessLucid pushes back Cosmos SUV launch as it resets finances, leaving a clearer opening for Tesla rivalsThe Apex TimesBusinessBooz Allen rolls out Vellox Ranger, an AI tool aimed at automating environment-specific cyber threat detectionThe Apex TimesBusinessMusk Flags Memory as a Key Constraint, Pointing to Rapid Demand Growth That Could Keep Prices ElevatedThe Apex TimesBusinessAMD reports revenue growth ahead of expectations, but shares slip as investors question where orders are coming fromThe Apex TimesBusinessPalantir shares surge, prompting ARK to trim stake while Wall Street traders debate the upsideThe Apex TimesBusinessArk Invest grows a roughly $870 million Tesla position as Cathie Wood doubles down on the disruption thesisThe Apex TimesBusinessJohnson & Johnson’s leadership shuffle renews debate over valuation after executive retirementThe Apex TimesBusinessAMD warns stronger-than-expected server CPU demand is tightening supply, but CEO Lisa Su expects 2027 to improveThe Apex TimesBusinessPfizer, Merck and Amgen ramp up cancer-focused partnerships as trading chatter swirls around SLS and IBRXThe Apex TimesBusinessApple heads to trial in Illinois biometric lawsuit tied to facial recognition in PhotosThe Apex TimesBusinessFiserv and Mastercard expand partnership aimed at simplifying merchants’ access to digital payments servicesThe Apex TimesBusinessEli Lilly wins FDA Breakthrough Therapy designation for olomorasib in KRAS G12C-mutant advanced pancreatic cancerThe Apex TimesBusinessLucid pushes back Cosmos SUV launch as it resets finances, leaving a clearer opening for Tesla rivalsThe Apex TimesBusinessBooz Allen rolls out Vellox Ranger, an AI tool aimed at automating environment-specific cyber threat detectionThe Apex TimesBusinessMusk Flags Memory as a Key Constraint, Pointing to Rapid Demand Growth That Could Keep Prices ElevatedThe Apex TimesBusinessAMD reports revenue growth ahead of expectations, but shares slip as investors question where orders are coming fromThe Apex TimesBusinessPalantir shares surge, prompting ARK to trim stake while Wall Street traders debate the upsideThe Apex TimesBusinessArk Invest grows a roughly $870 million Tesla position as Cathie Wood doubles down on the disruption thesisThe Apex TimesBusinessJohnson & Johnson’s leadership shuffle renews debate over valuation after executive retirementThe Apex TimesBusinessAMD warns stronger-than-expected server CPU demand is tightening supply, but CEO Lisa Su expects 2027 to improveThe Apex TimesBusinessPfizer, Merck and Amgen ramp up cancer-focused partnerships as trading chatter swirls around SLS and IBRXThe Apex TimesBusinessApple heads to trial in Illinois biometric lawsuit tied to facial recognition in PhotosThe Apex TimesBusinessFiserv and Mastercard expand partnership aimed at simplifying merchants’ access to digital payments servicesThe Apex TimesBusinessEli Lilly wins FDA Breakthrough Therapy designation for olomorasib in KRAS G12C-mutant advanced pancreatic cancerThe Apex Times
Back to front
Leidos Shares Rise After Company Lifts 2026 Revenue Outlook and Cites New Defense AI Work
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 5, 2:29 AM EDT

Leidos Shares Rise After Company Lifts 2026 Revenue Outlook and Cites New Defense AI Work

Leidos Holdings reported Q2 results and raised its full-year 2026 revenue outlook, while GAAP net income and earnings per share were lower year over year. The update helped lift the stock about 10% in early trading.

3 min readEditor-approved Apex article

Leidos Holdings Inc. (LDOS) moved higher after reporting its second-quarter 2026 results and increasing its outlook for full-year revenue, a combination investors appeared to reward even as profitability measures declined versus the same quarter a year earlier. The company’s shares were up roughly 10% on the day of the update, according to the market recap that carried the announcement.

In the quarter, Leidos reported revenue of about US$4.56 billion. The company also reported that GAAP net income and GAAP earnings per share (EPS) eased compared with the prior year period, indicating that while sales grew, the bottom line was under pressure. The report did not provide additional detail in the available coverage on the specific drivers of the year-over-year change in GAAP profitability.

Alongside the quarterly numbers, Leidos raised its full-year 2026 revenue outlook. While the coverage did not include the size of the increase or the new guidance range, the decision to lift expectations indicated management’s confidence in the pace of business, particularly in areas tied to government spending and technology modernization.

The company also pointed to winning new defense work associated with artificial intelligence, according to the same market recap. In this context, “AI work” generally refers to contracts and programs that use machine learning and related techniques to support defense missions, such as analysis, decision support, and operations. Leidos did not specify in the available coverage which programs it won, the contract values, or the expected timing of revenue recognition.

Leidos operates in the defense and intelligence services arena, providing systems and engineering support for government customers. That segment is often sensitive to how quickly agencies move from contracting to execution, as revenue can track project schedules, contract awards, and mission priorities. As a result, investors frequently react to changes in guidance because raised revenue targets can indicate better visibility into future deliverables.

Sector-wide, defense contractors have faced an elevated focus on digital transformation, including AI-enabled capabilities. In that environment, awards for AI-related work can matter because they may expand the addressable pipeline, support follow-on contracts, and help companies position themselves for modernization efforts that are increasingly tied to data and software capabilities rather than only traditional engineering scope. The coverage available here only stated that Leidos won additional defense AI work, without disclosing the breadth of those wins.

Even with the positive stock reaction, the update leaves several items unclear from the information provided. The coverage did not detail the revised 2026 revenue outlook amount, whether the raise reflected broader strength across segments or a narrower set of programs, or how GAAP net income and EPS declines map to expense patterns, margins, or one-time items. It also did not break out the timing and expected contribution of the defense AI contracts to future quarters.

Investors will likely look next for more complete guidance disclosures and segment-level performance, including any reconciliation between the guidance increase and the year-over-year decline in GAAP profitability. Any additional detail on the newly won defense AI work, such as contract scope, expected revenue timing, and key customer agencies, would help clarify whether the outlook lift is tied to durable multi-year demand or near-term project momentum.

Why It Matters

  • A raised full-year 2026 revenue outlook can announcement improved visibility into government-funded work, which is often a key driver for defense contractors’ market valuations.
  • GAAP profitability moving opposite to revenue growth can be a near-term overhang, so investors may watch whether margins stabilize in later quarters.
  • AI-related defense contract wins may indicate continued demand for technology services tied to modern defense missions, but investors will likely want scope and revenue timing details.
  • The gap between guidance strength and weaker GAAP results may shape how the market interprets execution and cost trends going forward.

Sources

Key Facts

  • Leidos reported Q2 2026 revenue of about US$4.56 billion.
  • In that quarter, Leidos GAAP net income and GAAP EPS declined year over year, even as revenue increased.
  • Leidos raised its full-year 2026 revenue outlook.
  • The company cited winning new defense artificial intelligence (AI) work.
  • Leidos shares rose about 10% following the update, based on the market recap.

Defense Related